Advance Your Practice with Accredited Insights
Are you ready to revolutionize your approach to Prurigo Nodularis (PN) care? Dive into the latest advancements alongside renowned nurse practitioner experts, Margaret Bobonich and Leigh Ann Pansch. Earn 1.00 contact hours of continuing education (CE) credit as you explore cutting-edge treatments and develop personalized strategies to elevate your clinical practice.
The Evolution of PN Care
Previously, treatment options for PN were limited, often relying on off-label use of therapies with varying degrees of efficacy and significant side effects. However, with recent advancements shedding light on the molecular drivers of inflammation and pruritus, a new era of disease-modifying treatments has emerged.
In September 2022, dupilumab marked a groundbreaking milestone as the first FDA-approved treatment for PN. This pivotal moment paved the way for a transformative shift in PN care, offering hope and relief to patients burdened by this distressing condition.
What You'll Learn
Distinguish PN from other dermatological conditions with confidence.
Identify key immune modulators driving PN pathology.
Develop evidence-based treatment plans tailored to your patients' needs.
